Colazal News

Salix's Colazal Conundrum - Forbes

The Raleigh, NC-based company’s shares started tumbling on Friday the firm learned its drug Colazal, which is also used to treat ulcerative colitis, ...

http://www.forbes.com/markets/eco... | Posted: Mon Dec 31 18:10:39 -0500 2007

Market Watch - Sun-Sentinel.com

... lost one-third of its value in three trading days as drugmakers began introducing copies of its top-selling product, the anti-inflammatory pill Colazal. ...

http://www.sun-sentinel.com/busin... | Posted: Tue Jan 01 03:01:39 -0500 2008

Mylan receives final FDA approval for generic ulcerative colitis drug - CNNMoney.com

The capsules are a generic form of Salix Pharmaceuticals's (NASDAQ:SLXP) Colazal product. Mylan, a Pittsburgh-based pharmaceutical company, expects to begin ...

http://money.cnn.com/news/newsfee... | Posted: Mon Dec 31 08:13:13 -0500 2007

Macy's among big movers on Wall Street - CNNMoney.com

Several drug developers received approval for their generic versions of the company's key product, Colazal, which is used to treat ulcerative colitis.

Posted: Mon Dec 31 13:42:59 -0500 2007

Generic competition pummels Salix shares - Charlotte Business Journal

Raleigh-based Salix (Nasdaq: SLXP) announced Friday that it is partnering with Watson Pharmaceuticals to create a generic version of Colazal, ...

http://charlotte.bizjournals.com/... | Posted: Tue Jan 01 01:44:14 -0500 2008

Salix, Watson Launch Authorized Generic Of COLAZAL - Quick Facts - Trading Markets (press release)

... an agreement with Watson Pharma, pursuant to which Watson will market and sell an authorized generic of COLAZAL or balsalazide disodium Capsules. ...

http://www.tradingmarkets.com/.si... | Posted: Fri Dec 28 17:58:51 -0500 2007

Roxane Laboratories， Inc. Announces the Launch of Balsalazide ... - 金融界

Roxane Laboratories'' Balsalazide Disodium Capsules, 750mg are AB rated to COLAZAL? (balsalazide disodium). Annual sales of Balsalazide Disodium Capsules, ...

http://usstock.jrj.com.cn/news/20... | Posted: Wed Jan 02 16:41:00 -0500 2008

Salix Announces Launch of COLAZAL(R) Authorized Generic with Watson - WELT ONLINE

Carolyn Logan, President and Chief Executive Officer, stated, "Salix is committed to aggressively protecting its COLAZAL business and growing market share ...

http://newsticker.welt.de/index.p... | Posted: Fri Dec 28 17:47:45 -0500 2007

Options update: Salix volume heavy, volatility Spikes to 104 as ... - BloggingStocks

SLXP weakness was attributable to concerns of Colazal generic competition. SLXP call option volume of 9940 contracts compares to put volume of 8890 ...

Posted: Fri Dec 28 18:09:00 -0500 2007